¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
¼¼°è ÀüÀÚ ÀÓ»ó °á°ú Æò°¡(eCOA) ½ÃÀåÀº 2024³â 17¾ï 4,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2024-2031³â°£ ¿¬Æò±Õ 14.9% ¼ºÀåÇÏ¿© 2031³â¿¡´Â 45¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
±×¸² 1. 2024³â ÀüÀÚ ÀÓ»ó °á°ú Æò°¡(eCOA) ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2024³â

eCOA(Electronic Clinical Outcome Assessment, ÀüÀÚ ÀÓ»ó °á°ú Æò°¡)´Â ½º¸¶Æ®Æù, ÀüÀÚ ¼öø/³ëÆ®ºÏ, ÅÂºí¸´ µî µðÁöÅÐ ±â±â¸¦ ÅëÇØ ȯÀÚ³ª º¸È£ÀڷκÎÅÍ Á÷Á¢ ÀÓ»ó½ÃÇèÀÇ ¿£µåÆ÷ÀÎÆ® µ¥ÀÌÅ͸¦ ÀüÀÚÀûÀ¸·Î ¼öÁýÇÏ´Â ¹æ¹ýÀ» ¸»ÇÕ´Ï´Ù. eCOAÀÇ ÁÖ¿ä ÀÌÁ¡À¸·Î´Â ÀÀ´äÀÌ µðÁöÅзΠ±â·ÏµÇ±â ¶§¹®¿¡ µ¥ÀÌÅÍÀÇ Á¤È®¼º°ú ¿ÏÀü¼ºÀÌ Çâ»óµÇ°í, µ¥ÀÌÅÍ ÀÔ·Â ¿À·ù°¡ °¨¼ÒÇϸç, µ¥ÀÌÅÍ º¸¾ÈÀÌ °ÈµÇ°í, ÀÓ»ó ¿¬±¸ÀÚ ¹× º¸È£ÀÚÀÇ µ¥ÀÌÅÍ º¸¾ÈÀÌ °ÈµÈ´Ù´Â Á¡ µîÀÌ ÀÖ½À´Ï´Ù. µ¥ÀÌÅÍ ÀÔ·Â ¿À·ù °¨¼Ò, µ¥ÀÌÅÍ º¸¾È °È, ÀÓ»ó ¿¬±¸ ±â°ü ¹× Á¦¾à»ç ½ºÆù¼°¡ °á°ú¸¦ ºü¸£°Ô ¾òÀ» ¼ö ÀÖ´Ù´Â Á¡ µîÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ ÀÓ»ó½ÃÇè¿¡¼ eCOA ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå ¿ªÇÐ
¼¼°è ÀüÀÚ ÀÓ»ó °á°ú Æò°¡ ½ÃÀåÀº ÀÓ»ó½ÃÇèÀÇ È¿À²È¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡, Á¦¾à»çÀÇ R&D ÅõÀÚ Áõ°¡, eCOA ¼Ö·ç¼ÇÀÌ Á¦°øÇÏ´Â ½Ç½Ã°£ µ¥ÀÌÅÍ ¼öÁý ±â´É¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ±àÁ¤ÀûÀÎ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ±×·¯³ª ¹Î°¨ÇÑ È¯ÀÚ Á¤º¸ÀÇ ÀüÀÚÀû ¼öÁý°ú °ü·ÃµÈ µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹× º¸¾È¿¡ ´ëÇÑ ¿ì·Á´Â ¿©ÀüÈ÷ Å« µµÀü°úÁ¦·Î ³²¾ÆÀÖ½À´Ï´Ù. ºñÁî´Ï½º ±âȸ Ãø¸é¿¡¼´Â ÀÓ»ó ¿¬±¸¿¡¼ ¸ð¹ÙÀÏ Çコ ¹× ¿þ¾î·¯ºí ±â±âÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå Âü¿©Àڵ鿡°Ô »õ·Î¿î ±æÀ» ¿¾îÁÙ °ÍÀ¸·Î ±â´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÅÈï ½ÃÀå¿¡¼ÀÇ ÀÓ»ó½ÃÇè ½Ã¼³ÀÇ Áö¼ÓÀûÀÎ È®ÀåÀº ¿ø°Ý eCOA Á¢±Ù ¹æ½ÄÀÇ Ã¤ÅÃÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡
- ÀÌ º¸°í¼´Â 2023³âÀ» ±âÁØ¿¬µµ·Î ÇÏ¿© 2024³âºÎÅÍ 2031³â±îÁö ¿¹Ãø ±â°£(2024-2031³â) ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ÅëÇØ Àü ¼¼°è ÀüÀÚ ÀÓ»ó °á°ú Æò°¡(eCOA) ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®Çß½À´Ï´Ù.
- ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ¼ºÀå ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
- ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÑ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °íÂûµµ Á¦°øÇÕ´Ï´Ù.
- ¼¼°è ÀüÀÚ ÀÓ»ó °á°ú Æò°¡ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±âÁØÀ¸·Î Á¤¸®Çß½À´Ï´Ù.
- ÁÖ¿ä ±â¾÷À¸·Î´Â IQVIA Inc., Medidata, Signant Health, Oracle, Parexel International Corporation, Obvio Health USA, Inc. Clinical, ClinCapture, EvidentIQ Group GmbH, Clario, Cloudbyz, Veeva Systems, Merative, Medable Inc. µîÀÌ ÀÖ½À´Ï´Ù.
- ÀÌ º¸°í¼ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
- ¼¼°è ÀüÀÚ ÀÓ»ó °á°ú Æò°¡ ½ÃÀåÀº ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
- ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ÀüÀÚ ÀÓ»ó °á°ú Æò°¡ ½ÃÀåÀ» ºÐ¼®ÇÒ ¶§ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç
Á¦2Àå ½ÃÀå Àü¸Á
- º¸°í¼ ¼³¸í
- ÁÖ¿ä ¿ä¾à
- Coherent Opportunity Map (COM)
Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®
- ½ÃÀå ¿ªÇÐ
- ¼ºÀå ÃËÁø¿äÀÎ
- ¼ºÀå ¾ïÁ¦¿äÀÎ
- ±âȸ
- ¿µÇ⠺м®
- ½ÃÀå µ¿Çâ
- ±ÔÁ¦ ½Ã³ª¸®¿À
- Àμö ¹× Á¦ÈÞ ½Ã³ª¸®¿À
- Á¦Ç° ¹ß¸Å/½ÂÀÎ
- ºê·£µå¿Í °¡°Ý ºÐ¼®
- ÆÝµù ¹× ÅõÀÚ
- PEST ºÐ¼®
- PorterÀÇ Five Forces ºÐ¼®
Á¦4Àå ¼¼°èÀÇ ÀüÀÚ ÀÓ»ó °á°ú Æò°¡ ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ
- ÀüüÀûÀÎ ¿µÇâ
- Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê
- ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ
Á¦5Àå ¼¼°èÀÇ ÀüÀÚ ÀÓ»ó °á°ú Æò°¡ ½ÃÀå, Á¦°ø Çüź°, 2019-2031³â(10¾ï ´Þ·¯)
- ¼·Ð
- À¥ È£½ºÆ®
- Ŭ¶ó¿ìµå ±â¹Ý
Á¦6Àå ¼¼°èÀÇ ÀüÀÚ ÀÓ»ó °á°ú Æò°¡ ½ÃÀå, Á¢±Ùº°, 2019-2031³â(10¾ï ´Þ·¯)
- ¼·Ð
- ȯÀÚ º¸°í ¼º°ú(PRO)
- ÀÓ»óÀÇ º¸°í ¼º°ú(ClinRO)
- °üÂûÀÚ º¸°í ¼º°ú(ObsRO)
- ÆÛÆ÷¸Õ½º °á°ú(PerfO)
Á¦7Àå ¼¼°èÀÇ ÀüÀÚ ÀÓ»ó °á°ú Æò°¡ ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2031³â(10¾ï ´Þ·¯)
- ¼·Ð
- Á¦¾à ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö
- º´¿ø/ÀÇ·á Á¦°ø¾÷ü
- °è¾à ¿¬±¸±â°ü
- ±âŸ
Á¦8Àå ¼¼°èÀÇ ÀüÀÚ ÀÓ»ó °á°ú Æò°¡ ½ÃÀå, Áö¿ªº°, 2019-2031³â(10¾ï ´Þ·¯)
- ¼·Ð
- ¶óƾ¾Æ¸Þ¸®Ä«
- À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- 秵Á¦9Àå °æÀï ±¸µµ
- ±â¾÷ °³¿ä
- IQVIA Inc
- Medidata
- Signant Health
- Oracle
- Parexel International Corporation
- Obvio Health USA, Inc.
- Clinion
- Kayentis
- WCG Clinical
- clincapture
- EvidentIQ Group GmbH
- Clario
- Cloudbyz
- Veeva Systems
- Merative
- Medable Inc.
Á¦10Àå ¾Ö³Î¸®½ºÆ®ÀÇ Ãßõ »çÇ×
- À¶¼º°ú ¼èÅð
- COM(Coherent Opportunity Map)
Á¦11Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý
LSH 24.07.12
Global electronic clinical outcome assessment (eCOA) market is estimated to be valued at USD 1.74 Bn in 2024 and is expected to reach USD 4.59 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 14.9% from 2024 to 2031.
Figure 1. Electronic Clinical Outcome Assessment (eCOA) Market Share (%), By Region, 2024

Electronic Clinical Outcome Assessment (eCOA) refers to the method of collecting clinical trial endpoint data electronically from patients and caregivers directly via digital devices such as smartphones, electronic diaries/notebooks, or computer tablets. It allows clinical trial data to be captured electronically in real-time which improves data quality and reduces delays associated with paper-based methods. Some key advantages of eCOA include improved accuracy and completeness of data as responses are recorded digitally, reduced data entry errors, better data security along with faster availability of results for clinical research organizations and pharmaceutical sponsors. Growing awareness about these benefits is primarily driving the increased adoption of eCOA solutions in clinical trials.
Market Dynamics:
The global electronic clinical outcome assessment market is witnessing positive growth driven by factors such as rising need to improve clinical trial efficiency, increasing R&D investments in drug development by pharmaceutical companies, and growing preference for real-time data capture capabilities offered by eCOA solutions. However, data privacy and security concerns associated with electronic collection of sensitive patient information still persist which is a major challenge. On the opportunity side, rising application of mobile health and wearable devices in clinical research is expected to provide new avenues for market players. Also, continued expansion of clinical trial sites in emerging markets will further support the adoption of remote eCOA approaches.
Key Features of the Study:
- This report provides an in-depth analysis of the global electronic clinical outcome assessment (eCOA) market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global electronic clinical outcome assessment (eCOA) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this includes IQVIA Inc, Medidata, Signant Health, Oracle, Parexel International Corporation, Obvio Health USA, Inc., Clinion, Kayentis, WCG Clinical, N?linN?apture, EvidentIQ Group GmbH, Clario, Cloudbyz, Veeva Systems, Merative, and Medable Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global electronic clinical outcome assessment (eCOA) market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global electronic clinical outcome assessment (eCOA) market
Detailed Segmentation-
- By Delivery Mode:
- By Approach:
- Patient-reported Outcome (PRO)
- Clinician-reported Outcome (ClinRO)
- Observer-reported Outcome (ObsRO)
- Performance Outcome (PerfO)
- By End User:
- Pharmaceutical & Biotechnology
- Hospitals/Healthcare Providers
- Contract Research Organizations
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- IQVIA Inc
- Medidata
- Signant Health
- Oracle
- Parexel International Corporation
- Obvio Health USA, Inc.
- Clinion
- Kayentis
- WCG Clinical
- N?linN?apture
- EvidentIQ Group GmbH
- Clario
- Cloudbyz
- Veeva Systems
- Merative
- Medable Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Delivery Mode
- Market Snapshot, By Approach
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Product Launches/Approvals
- Brand and Pricing Analysis
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Electronic Clinical Outcome Assessment (eCOA) Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Electronic Clinical Outcome Assessment (eCOA) Market, By Delivery Mode, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Web-hosted
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cloud-based
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Electronic Clinical Outcome Assessment (eCOA) Market, By Approach, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Patient-reported Outcome (PRO)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Clinician-reported Outcome (ClinRO)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Observer-reported Outcome (ObsRO)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Performance Outcome (PerfO)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Electronic Clinical Outcome Assessment (eCOA) Market, By End User, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Pharmaceutical & Biotechnology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Hospitals/Healthcare Providers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Contract Research Organizations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Electronic Clinical Outcome Assessment (eCOA) Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Approach, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Approach, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Approach, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Approach, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Approach, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Approach, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- IQVIA Inc*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Medidata
- Signant Health
- Oracle
- Parexel International Corporation
- Obvio Health USA, Inc.
- Clinion
- Kayentis
- WCG Clinical
- clincapture
- EvidentIQ Group GmbH
- Clario
- Cloudbyz
- Veeva Systems
- Merative
- Medable Inc.
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact